Search
for
Sort by
Research 121–150 of 160
- A comment on a study of donor area in follicular unit hair transplantation
- The potential for occupational exposure of veterinarians to ketamine resulting in positive drug tests
- Men??s Health
- The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH
- This Month in Adult Urology
- Hormonal manipulation of benign prostatic hyperplasia
- Pembrolizumab-Induced Autoimmune Hepatitis
- Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential
- BPH: costs and treatment outcomes.
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis
- 1304 Assessing Post Operative Continuation of LUTs Medication Following TURP and BiPolep
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
- Practical Geriatrics: Men's Sexual Health After Midlife
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Weak correlations between serum and cerebrospinal fluid levels of estradiol, progesterone and testosterone in males
- Recent advances in treatment for Benign Prostatic Hyperplasia
- The composition of cell‐based therapies obtained from point‐of‐care devices/systems which mechanically dissociate lipoaspirate: a scoping review of the literature
- Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Plasma Therapy Gains Attention in Treatment of Viral Infections, Dermatological Illness, and Orthopedic Illnesses
- Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Global online interest in finasteride sexual side effects
- Underactive bladder - an underestimated entity